Kwancharoen Ratchaneewan, Blitz Ari M, Tavares Fabiana, Caturegli Patrizio, Gallia Gary L, Salvatori Roberto
Division of Endocrinology and Metabolism, Department of Medicine, Pituitary Center, Johns Hopkins University School of Medicine Baltimore, 1830 East Monument Street #333, Baltimore, MD, 21287, USA.
Pituitary. 2014 Aug;17(4):342-8. doi: 10.1007/s11102-013-0507-z.
Meningiomas account for about 1% of sellar masses. Although they can mimic pituitary adenomas, they are more vascularized and invasive. To gain insights that would enhance our ability to establish a pre-surgical diagnosis of meningioma, we performed a retrospective study of these tumors. Query of the surgical pathology database identified 1,516 meningiomas operated at out institution between January 2000 and May 2012. Cases were matched to the radiology database to identify a strictly defined sellar and/or suprasellar location. We identified 57 meningiomas. F:M ratio was 6:1. The mean age was 52 years (median 50, range 30-78). The most common symptoms were visual disturbance (58%), headache (16%) and incidental finding (12%). The mean duration of symptoms was 13 months. Hyperprolactinemia was found in 36%, with mean value of 51.6 ng/ml (median 41.8, range 22.5-132). Mean maximal diameter was 2.9 cm (median 2.7, range 0.9-6.8), and most tumors enhanced homogeneously on MRI after gadolinium. A "dural tail" sign was reported in a third. The radiologist reported "likely meningioma" in 65%, "possible meningioma" in 8.7%, and pituitary adenoma in 11%. After surgery, visual disturbances improved in most patients (80%) but headache only in 7%. Post-operative complications at 1 and 3 months occurred 38.6 and 33.3% respectively. There was no mortality. Sellar/suprasellar meningiomas represent 4% of all meningiomas, and have a particularly high female predominance. The diagnosis is suggested by the radiologist in approximately 2/3 of the cases. An improved method to differentiate preoperatively these tumors from adenomas would be desirable.
脑膜瘤约占鞍区肿块的1%。尽管它们可类似垂体腺瘤,但血管化程度更高且具有侵袭性。为了获得有助于提高我们术前诊断脑膜瘤能力的见解,我们对这些肿瘤进行了一项回顾性研究。查询手术病理数据库,确定了2000年1月至2012年5月在我们机构接受手术的1516例脑膜瘤。将病例与放射学数据库匹配,以确定严格定义的鞍区和/或鞍上位置。我们识别出57例脑膜瘤。男女比例为6:1。平均年龄为52岁(中位数50岁,范围30 - 78岁)。最常见的症状是视力障碍(58%)、头痛(16%)和偶然发现(12%)。症状的平均持续时间为13个月。36%的患者存在高催乳素血症,平均值为51.6 ng/ml(中位数41.8,范围22.5 - 132)。平均最大直径为2.9 cm(中位数2.7,范围0.9 - 6.8),大多数肿瘤在钆增强MRI上呈均匀强化。三分之一的病例报告有“硬膜尾征”。放射科医生报告“可能为脑膜瘤”的占65%,报告“可能是脑膜瘤”的占8.7%,报告为垂体腺瘤的占11%。手术后,大多数患者(80%)的视力障碍有所改善,但只有7%的患者头痛得到改善。术后1个月和3个月的并发症发生率分别为38.6%和33.3%。无死亡病例。鞍区/鞍上脑膜瘤占所有脑膜瘤的4%,女性优势尤为明显。约三分之二的病例放射科医生可做出诊断。需要一种改进的方法来术前将这些肿瘤与腺瘤区分开来。